The molecule was first identified and studied by the Sikiric research group in Croatia starting in the early 1990s, and the bulk of the preclinical evidence base comes from more than three decades of rat and rodent studies showing consistent tissue-repair, anti-inflammatory, and gastroprotective effects
Absolute contraindications include active malignancy, pregnancy, and lactation
This 15-amino acid fragment is also frequently referred to as Body Protection Compound (BPC)
Labs should align their internal protocols with these principles
Therefore, I do not offer BPC-157 in any formeither as injections or oral supplements
The preservatives strength reduces once the vial is exposed to air, light, or temperature changes